Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2021-04-01 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
425 Filing
Regulatory Filings
2021-04-01 English
425 Filing
Regulatory Filings
2021-04-01 English
NOTICE OF AGM
Foreign Filer Report
2021-03-30 English
Proxy Form
AGM Information Classification · 99% confidence The document explicitly mentions the 'Annual General Meeting' (AGM) multiple times, including the date, location, and details about voting procedures via a 'Proxy Form'. It also references an accompanying 'shareholder engagement event' which is related to the AGM. The core content is the mechanism for shareholders to vote on resolutions for the upcoming AGM. This directly aligns with the definition of 'AGM Information' (AGM-R), which covers presentations and materials shared during the AGM, and the proxy form is a key material for the meeting.
2021-03-30 English
Notice of AGM
AGM Information Classification · 100% confidence The document explicitly begins with the title "Notice of AGM" and "Notice of Annual General Meeting 2021 and Shareholders' Circular". It details the arrangements for the upcoming Annual General Meeting (AGM) on Tuesday 11 May 2021, including procedures due to COVID-19 restrictions, and outlines the resolutions to be voted upon (Accounts, Dividend, Auditor reappointment, Director elections/re-elections, Remuneration Report/Policy, Political donations, and Allotment of new shares). This content is characteristic of materials sent to shareholders to inform them about the meeting and solicit their votes, which aligns perfectly with the definition of an AGM-related document, specifically a Notice of Meeting/Shareholders' Circular. While it mentions the Annual Report and Remuneration Report, the document itself is the notice calling the meeting and presenting the business to be conducted there, making 'AGM-R' the most appropriate classification over '10-K' or 'DEF 14A'.
2021-03-30 English
FORM 6-K
Foreign Filer Report
2021-03-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.